Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3179.00    95.00 (3.08%)
Bid:
3186.00
Ask:
3188.00
Spread: 2.00 (0.063%)
Market Cap: £4.43b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Acquisition

24 May 2013 07:00

RNS Number : 4809F
Croda International PLC
24 May 2013
 



24 May 2013

 

Croda International Plc

 

Acquisition ofSpecialty Products Business from Arizona Chemical

Naturally derived polyamides expand Croda's broad portfolio of effects

 

Croda International Plc announces today that it has completed the acquisition of the Specialty Products business of Arizona Chemical based in Jacksonville, Florida in the USA. 

 

The acquisition adds a portfolio of class leading oil gelling polymers to Croda's business and further expands its footprint in the polymers arena, while strengthening Croda's leading position in speciality chemicals derived from renewable resources. The technologies and products of the acquired business are naturally derived polyamides with high bio-renewable content, covered by a range of patents.

 

Keith Layden, Croda's Chief Technology Officer, said:

 

"This acquisition represents further progress in our strategy to acquire complementary new technologies. The varied functionality of these specialised polyamides will be a valuable addition to our offerings across both the Consumer Care and Performance Technologies market sectors. In addition, there are a number of opportunities to further differentiate the technology and create value for ourselves and our customers."

 

No manufacturing assets will be acquired as part of this transaction and Croda will immediately commence the relocation of the products to Croda's Mevisa manufacturing site in Spain and when ready, re-launch the products with new trade names and marketing identities.

 

For further information please contact:

 

Keith Layden, Chief Technology Officer Tel: 01405 860 551

Sean Christie, Group Finance Director

 

Charles Armitstead / Rosie Oddy, Pendomer Communications Tel: 020 3603 5224 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQAJMATMBJTBFJ
Date   Source Headline
13th Mar 202011:58 amRNSDirector/PDMR Shareholding
13th Mar 202011:57 amRNSDirector/PDMR Shareholding
13th Mar 202011:57 amRNSDirector/PDMR Shareholding
13th Mar 202011:56 amRNSDirector/PDMR Shareholding
11th Mar 20202:13 pmRNSDirector/PDMR Shareholding
10th Mar 20204:11 pmRNSDirector/PDMR Shareholding
25th Feb 20207:00 amRNSResults for the year ended 31 December 2019
12th Feb 20203:47 pmRNSHolding(s) in Company
11th Feb 20203:14 pmRNSDirector/PDMR Shareholding
31st Jan 20204:22 pmRNSHolding(s) in Company
30th Jan 20202:36 pmRNSHolding(s) in Company
14th Jan 20203:42 pmRNSHolding(s) in Company
13th Jan 20204:12 pmRNSDirector/PDMR Shareholding
30th Dec 201911:45 amRNSDirector/PDMR Shareholding
20th Dec 20194:00 pmRNSHolding(s) in Company
17th Dec 20194:52 pmRNSHolding(s) in Company
16th Dec 20197:00 amRNSDirectorate Change
12th Dec 201910:40 amRNSDirector/PDMR Shareholding
9th Dec 20193:21 pmRNSHolding(s) in Company
4th Dec 20195:11 pmRNSHolding(s) in Company
27th Nov 20195:13 pmRNSHolding(s) in Company
25th Nov 20193:47 pmRNSHolding(s) in Company
22nd Nov 201910:17 amRNSDirector/PDMR Shareholding
12th Nov 20195:41 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
7th Nov 20196:04 pmRNSHolding(s) in Company
7th Nov 201910:04 amRNSHolding(s) in Company
1st Nov 20194:45 pmRNSDirector/PDMR Shareholding
15th Oct 20194:54 pmRNSTransaction in Own Shares
11th Oct 20195:40 pmRNSDirector/PDMR Shareholding
7th Oct 20197:00 amRNSCroda investor seminar focusing on Life Sciences
3rd Oct 20194:20 pmRNSDirector/PDMR Shareholding
13th Sep 20192:27 pmRNSDirector/PDMR Shareholding
11th Sep 20193:00 pmRNSDirector/PDMR Shareholding
11th Sep 20192:28 pmRNSHolding(s) in Company
13th Aug 20194:12 pmRNSDirector/PDMR Shareholding
25th Jul 20193:35 pmRNSDirector/PDMR Shareholding
24th Jul 20197:00 amRNSResults for the six months ended 30 June 2019
11th Jul 20193:11 pmRNSDirector/PDMR Shareholding
14th Jun 20193:01 pmRNSDirector/PDMR Shareholding
4th Jun 20193:24 pmRNSDirector/PDMR Shareholding
13th May 20193:20 pmRNSDirector/PDMR Shareholding
3rd May 20192:59 pmRNSDirector/PDMR Shareholding
1st May 20194:32 pmRNSDirector/PDMR Shareholding
29th Apr 20198:54 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.